Neuronetics (NASDAQ:STIM) reported Q4 EPS of ($0.30), $0.08 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $16.81 million.
Neuronetics (NASDAQ:STIM) reported Q4 EPS of ($0.30), $0.08 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $18.2 million versus the consensus estimate of $16.81 million.